Att B_60dy FRN

66985

Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
The 2021 rotating sample adult core
will include questions that were
previously fielded in the 2019 NHIS
including items on chronic pain,
preventive screening tests and aspirin
use. New rotating core include items on
allergies and psychological distress,
both of which were fielded in the preredesigned NHIS. New sponsored
content includes items on epilepsy,
myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS), insulin
affordability, diabetes distress, A1C
testing, colorectal cancer, prostate
cancer, cervical cancer and breast
cancer screening, occupational health,
life satisfaction, hepatitis A and B
vaccination coverage, COVID–19
vaccination coverage, and loss of the
sense of taste and smell. New sponsored
cancer control content that focuses on
cancer screenings uses questions similar
to those used in the 2019 NHIS.
The 2021 rotating sample child core
will include items on stressful life
events previously fielded in 2019 and
on allergies, fielded in the preredesigned NHIS. New content included
for analyses in conjunction with the

adolescent follow-back study (see
below) includes items on social and
emotional support, bullying, health care
utilization and life satisfaction.
Beginning around July 1, interviewers
will ask the respondents for sample
children aged 12–17 (usually the parent
or guardian) for permission to contact
the adolescent by web, phone, or mail
and to ask follow-up questions about
topics (1) already included in the
sample child NHIS and (2) topics added
to the sample child specifically related
this follow-back. The adolescent
questionnaire will be conducted web
phone, or mail and include items on
general health and well-being, height
and weight, health care utilization,
content of care in past year (or at last
wellness visit), health care access, use of
complementary and alternative health,
physical activity, sleep, screen time,
cognition, concussions, behavior,
depression and anxiety, sexual
orientation and gender identity, mental
health care use and unmet need, social
support, stressful life events, bullying,
everyday discrimination, and
demographics. Items on the survey

environment and experience with the
survey will also be asked.
Like in past years, and in accordance
with the 1995 initiative to increase the
integration of surveys within the DHHS,
respondents to the 2021 NHIS will serve
as the sampling frame for the Medical
Expenditure Panel Survey conducted by
the Agency for Healthcare Research and
Quality. In addition, a subsample of
NHIS respondents and/or members of
commercial survey panels may be
identified to participate in short, webbased methodological and cognitive
testing activities to evaluate the
questionnaire and/or inform the
development of new rotating and
sponsored content using web and/or
mail survey tools. In the future, a
subsample of NHIS respondents may
also be re-contacted for a brief health
exam.
There is no cost to the respondents
other than their time. Clearance is
sought for three years, to collect data for
2021–2023. The total annualized burden
is estimated to be 42,845 hours.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Adult Household Member ...............................
Sample Adult ...................................................
Adult Family Member ......................................
Adult Family Member ......................................
Sample Child ...................................................
Sample Adult ...................................................
Adult Family Member ......................................

Household Roster ..........................................
Adult Questionnaire ........................................
Child Questionnaire ........................................
Methodological Projects .................................
Adolescent follow-back Survey ......................
Health Exam ...................................................
Reinterview Survey ........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–23265 Filed 10–20–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1071; Docket No. CDC–2020–
0108]
khammond on DSKJM1Z7X2PROD with NOTICES

Number of
respondents

Type of respondent

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

VerDate Sep<11>2014

16:58 Oct 20, 2020

Jkt 253001

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery. This Generic
Information Collection enables the CDC
to garner customer and stakeholder
feedback on service delivery through
routine surveys, focus groups, usability
testing, and customer comment cards.

SUMMARY:

CDC must receive written
comments on or before December 21,
2020.

DATES:

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

36,000
30,000
10,000
15,000
1,200
10,000
5,500

Number of
responses per
respondent
1
1
1
1
1
1
1

Average
burden per
response
(in hours)
4/60
48/60
19/60
20/60
16/60
45/60
5/60

You may submit comments,
identified by Docket No. CDC–2020–
0108 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
ADDRESSES:

E:\FR\FM\21OCN1.SGM

21OCN1

66986

Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices

khammond on DSKJM1Z7X2PROD with NOTICES

instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Generic Clearance for the Collection
of Qualitative Feedback on Agency
Service Delivery (OMB Control No.
0920–1071, Exp. 02/28/2021)—
Extension—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC/NCEZID is seeking a three-year
extension of OMB control No. 0920–
1071 to continue collecting routine
customer feedback on agency service
delivery. Executive Order 12862 directs

VerDate Sep<11>2014

16:58 Oct 20, 2020

Jkt 253001

Federal agencies to provide service to
the public that matches or exceeds the
best service available in the private
sector. In order to work continuously to
ensure that our programs are effective
and meet our customers’ needs, the
National Center for Emerging and
Zoonotic Infectious Diseases, Centers for
Disease Control and Prevention (CDC)
(hereafter the ‘‘Agency’’) seeks to obtain
OMB approval of a generic clearance to
collect qualitative feedback on our
service delivery. By qualitative
feedback, we mean information that
provides useful insights on perceptions
and opinions, but are not statistical
surveys that yield quantitative results
that can be generalized to the
population of study.
This collection of information is
necessary to enable the Agency to garner
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with our commitment to
improving service delivery. The
information collected from our
customers and stakeholders will help
ensure that users have an effective,
efficient, and satisfying experience with
the Agency’s programs. This feedback
will provide insights into customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Since the previous renewal in 2018,
NCEZID has utilized 0920–1071 on 10
different occasions. The total number of
responses was 15,585. The total number
of burden hours was 2,525.
Improving agency programs requires
ongoing assessment of service delivery,
by which we mean systematic review of
the operation of a program compared to
a set of explicit or implicit standards, as
a means of contributing to the
continuous improvement of the
program. The Agency will collect,
analyze, and interpret information
gathered through this generic clearance
to identify strengths and weaknesses of
current services and make
improvements in service delivery based
on feedback. The solicitation of
feedback will target areas such as
timeliness, appropriateness, accuracy of
information, courtesy, efficiency of
service delivery, and resolution of
issues with service delivery. Responses
will be assessed to plan and inform

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

efforts to improve or maintain the
quality of service offered to the public.
If this information is not collected, vital
feedback from customers and
stakeholders on the Agency’s services
will be unavailable.
The Agency will only submit a
collection for approval under this
generic clearance if it meets the
following conditions:
• Information gathered will be used
only internally for general service
improvement and program management
purposes and is not intended for release
outside of the agency (if released,
procedures outlined in Question 16 will
be followed);
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions; 1
• Information gathered will yield
qualitative information; the collections
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study;
• The collections are voluntary;
• The collections are low-burden for
respondents (based on considerations of
total burden hours, total number of
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the Federal
Government;
• The collections are noncontroversial and do not raise issues of
concern to other Federal agencies;
• Any collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future; and
• With the exception of information
needed to provide renumeration for
participants of focus groups and
cognitive laboratory studies, personally
identifiable information (PII) is
collected only to the extent necessary
and is not retained.
If these conditions are not met, the
Agency will submit an information
collection request to OMB for approval
through the normal PRA process.
To obtain approval for a collection
that meets the conditions of this generic
clearance, a standardized form
(Attachment C) will be submitted to
OMB along with supporting
documentation.
The types of collections that this
generic clearance covers include, but are
not limited to:
• Customer comment cards/complaint
forms
• Small discussion groups
• Focus Groups of customers, potential
customers, delivery partners, or
other stakeholders

E:\FR\FM\21OCN1.SGM

21OCN1

66987

Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
• Cognitive laboratory studies, such as
those used to refine questions or
assess usability of a website;
• Qualitative customer satisfaction
surveys (e.g., post-transaction
surveys; opt-out web surveys)

• In-person observation testing (e.g.,
website or software usability tests)

information collection to ensure
compliance with the terms of this
clearance prior to submitting each
collection to OMB. CDC requests
approval for an estimated 3,850 annual
burden hours. There are no costs to
respondents other than their time.

The Agency has established a
manager/managing entity to serve for
this generic clearance and will conduct
an independent review of each

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

General public ...................................

Online surveys .................................
Focus groups ...................................
In-person surveys .............................
Usability testing ................................
Customer comment cards ................

1,500
800
1,000
1,500
1,000

1
1
1
1
1

30/60
2
30/60
30/60
15/60

750
1,600
500
750
250

Total ...........................................

...........................................................

........................

........................

........................

3,850

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–23247 Filed 10–20–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[60Day-21–0199; Docket No. CDC–2020–
0107]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Application for Permit to Import
Biological Agents and Vectors of Human
Disease into the United States,
Application for Permit to Import or
Transport Live Bats, and Application for
Permit to Import Infectious Human
Remains into the United States (OMB
Control No. 0920–0199). The purpose of
this data collection is to support Section
361 of the Public Health Service (PHS)

SUMMARY:

VerDate Sep<11>2014

16:58 Oct 20, 2020

Jkt 253001

Act and to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession.
DATES: CDC must receive written
comments on or before December 21,
2020.
You may submit comments,
identified by Docket No. CDC–2020–
0199 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
ADDRESSES:

Centers for Disease Control and
Prevention

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

PO 00000

Frm 00062

Fmt 4703

Sfmt 4703

or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Import regulations for infectious
biological agents, infectious substances,
and vectors (42 CFR 71.54) (OMB
Control No. 0920–0199, Exp. 4/30/

E:\FR\FM\21OCN1.SGM

21OCN1